Correlation Between Magenta Therapeutics and Vincerx Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Magenta Therapeutics and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Magenta Therapeutics and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Magenta Therapeutics and Vincerx Pharma, you can compare the effects of market volatilities on Magenta Therapeutics and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Magenta Therapeutics with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Magenta Therapeutics and Vincerx Pharma.

Diversification Opportunities for Magenta Therapeutics and Vincerx Pharma

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Magenta and Vincerx is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Magenta Therapeutics and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Magenta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Magenta Therapeutics are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Magenta Therapeutics i.e., Magenta Therapeutics and Vincerx Pharma go up and down completely randomly.

Pair Corralation between Magenta Therapeutics and Vincerx Pharma

Given the investment horizon of 90 days Magenta Therapeutics is expected to generate 0.31 times more return on investment than Vincerx Pharma. However, Magenta Therapeutics is 3.22 times less risky than Vincerx Pharma. It trades about 0.16 of its potential returns per unit of risk. Vincerx Pharma is currently generating about 0.0 per unit of risk. If you would invest  72.00  in Magenta Therapeutics on August 31, 2024 and sell it today you would earn a total of  10.00  from holding Magenta Therapeutics or generate 13.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy8.56%
ValuesDaily Returns

Magenta Therapeutics  vs.  Vincerx Pharma

 Performance 
       Timeline  
Magenta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Magenta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Magenta Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Magenta Therapeutics and Vincerx Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Magenta Therapeutics and Vincerx Pharma

The main advantage of trading using opposite Magenta Therapeutics and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Magenta Therapeutics position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.
The idea behind Magenta Therapeutics and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments